Access cutting-edge ebv infection treatment through this clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Access ebv infection specialists in Milwaukee at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ebv infection treatment provided free
Related donor Epstein-Barr Virus (EBV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults with refractory EBV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD
Sponsor: New York Medical College
Check if you qualify for this ebv infection clinical trial in Milwaukee, WI
If you're searching for ebv infection treatment options in Milwaukee, WI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ebv infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.